News Jetrea Gets FDA Nod for Macular Adhesion by MedPage Today • 2012/10/19 • 0 Comments WASHINGTON (MedPage Today) -- The FDA has approved ocriplasmin (Jetrea) as the first nonsurgical treatment for symptomatic vitreomacular adhesion. Full Story →